These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6251721)

  • 1. 1,25(OH)2D3 is not the only D metabolite involved in the pathogenesis of osteomalacia.
    Rasmussen H; Baron R; Broadus A; DeFronzo R; Lang R; Horst R
    Am J Med; 1980 Sep; 69(3):360-8. PubMed ID: 6251721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological importance of vitamin D metabolism.
    Haussler MR; Chandler JS; Pike JW; Brumbaugh PF; Speer DP; Pitt MJ
    Prog Biochem Pharmacol; 1980; 17():134-42. PubMed ID: 6259650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of vitamin D metabolites on PTH secretion in man.
    Miravet L; Guéris J; Redel J; Norman A; Ryckewaert A
    Calcif Tissue Int; 1981; 33(3):191-4. PubMed ID: 6791781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
    Ritz E; Kreusser W; Boland R; Bommer J
    Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in our understanding of the vitamin D endocrine system.
    De Luca HF
    J Lab Clin Med; 1976 Jan; 87(1):7-26. PubMed ID: 173767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative effectiveness of vitamin D metabolites in increasing bone mineral solubility.
    Somerman MJ; Neuman WF
    Calcif Tissue Int; 1981; 33(2):159-65. PubMed ID: 6783272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
    Marcus R; Orner FB; Brickman AS
    Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of vitamin D: current status.
    DeLuca HF
    Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D-resistant rickets. A prototype of nutritional management of a genetic disorder.
    Deluca HF
    Curr Concepts Nutr; 1979; 8():3-32. PubMed ID: 230941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of vitamin D metabolites (25 OHD3--12,5 (OH)2D3--24.25 (OH)2D3--25.26 (OH)2D3) on vitamin D deficient rats.
    Queille ML; Miravet L; Bordier P; Redel J
    Biomedicine; 1978; 28(4):237-42. PubMed ID: 737274
    [No Abstract]   [Full Text] [Related]  

  • 15. Opposing effects of cyclic adenosine-3',5'-monophosphate and cyclic guanosine-3',5'-monophosphate on the metabolism of 24-hydroxyvitamin D3 in isolated chick renal tubules.
    Prince RL; Wark JD; Eisman JA; Danks JA; Larkins RG
    Horm Metab Res; 1983 Aug; 15(8):399-403. PubMed ID: 6311708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of 1,25(OH)2D3 on bone mineralization in vitamin D deficiency (author's transl)].
    Rombouts-Lindemans C; Huaux JP; Meersseman F; Withofs H; Nagant de Deuxchaisnes C
    Ann Endocrinol (Paris); 1979; 40(2):173-4. PubMed ID: 475313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism, function and clinical aspects of vitamin D.
    Wasserman RH
    Cornell Vet; 1975 Jan; 65(1):3-25. PubMed ID: 163168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kidney as an endocrine organ involved in the function of vitamin D.
    DeLuca HF
    Am J Med; 1975 Jan; 58(1):39-47. PubMed ID: 163578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.